{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:35:44Z","timestamp":1775756144198,"version":"3.50.1"},"reference-count":0,"publisher":"Wiley","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1067\/mcp.2001.113959","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T04:19:27Z","timestamp":1027570767000},"page":"158-168","source":"Crossref","is-referenced-by-count":206,"title":["Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin"],"prefix":"10.1111","volume":"69","author":[{"given":"T","family":"Furuta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","container-title":["Clinical Pharmacology & Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:13:51Z","timestamp":1699362831000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1067\/mcp.2001.113959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S0009-9236(01)48594-8"],"URL":"https:\/\/doi.org\/10.1067\/mcp.2001.113959","relation":{},"ISSN":["0009-9236"],"issn-type":[{"value":"0009-9236","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}